Introduction: Breast cancer liver metastases (BCLM) are considered as a systemic disease which is mainly treated with chemotherapy, while the role of surgical resection still remains to be well defined. The aim of the study is to analyse the survival and prognostic factors predictive of mortality in patients with BCLM treated by liver resection.
Material And Methods: A total of 21 patients were operated on between 1998-2008, with liver resection being performed on 12.